The safety of using anti-VEGF: Is there strength in numbers? Curtis LH, Hammill BG, Schulman KA, Cousins SW (2010) Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273–1279

Detalles Bibliográficos
Autores principales: Wong, David, Joussen, Antonia M.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Editors Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042111/
https://www.ncbi.nlm.nih.gov/pubmed/21210141
http://dx.doi.org/10.1007/s00417-010-1603-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042111/
https://www.ncbi.nlm.nih.gov/pubmed/21210141
http://dx.doi.org/10.1007/s00417-010-1603-7

Ejemplares similares